Cargando…
PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil
Immune checkpoint blockade (ICB) agents are prominent immunotherapies for the treatment of advanced melanoma. However, they fail to promote any durable clinical benefit in a large cohort of patients. This study assessed clinical and molecular predictors of ICB response and survival in advanced melan...
Autores principales: | Sorroche, Bruna Pereira, Teixeira, Renan de Jesus, Pereira, Caio Augusto Dantas, Santana, Iara Viana Vidigal, Vujanovic, Lazar, Vazquez, Vinicius de Lima, Arantes, Lidia Maria Rebolho Batista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047789/ https://www.ncbi.nlm.nih.gov/pubmed/36980349 http://dx.doi.org/10.3390/diagnostics13061041 |
Ejemplares similares
-
TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients
por: Arantes, Lidia Maria Rebolho Batista, et al.
Publicado: (2020) -
MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol
por: Arantes, Lidia Maria Rebolho Batista, et al.
Publicado: (2016) -
Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid
por: Gama, Ricardo Ribeiro, et al.
Publicado: (2021) -
Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
por: Tostes, Katiane, et al.
Publicado: (2023) -
In-depth transcriptome reveals the potential biotechnological application of Bothrops jararaca venom gland
por: Pereira, Leandro de Mattos, et al.
Publicado: (2020)